[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.163.166.22. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Medical News & Perspectives
September 2, 2009

Institute of Medicine Outlines Priorities for Comparative Effectiveness Research

JAMA. 2009;302(9):936-937. doi:10.1001/jama.2009.1186

A new Institute of Medicine (IOM) report outlines priorities for a government-supported comparative effectiveness research program, including research comparing therapies for various conditions, studies to assess the best methods for health care delivery, and assessments of the effectiveness of preventive public health campaigns.

The report was ordered by Congress as part of a $1.1 billion appropriation in the American Recovery and Reinvestment Act of 2009 intended to boost comparative effectiveness research. In addition to identifying 100 health topics that should be addressed by this effort, the report makes a series of recommendations for establishing and carrying out a robust research program in this area, including a call for the Department of Health and Human Services (DHHS) to establish a coordinating body to oversee US-funded comparative effectiveness research.

First Page Preview View Large
First page PDF preview
First page PDF preview
×